Hereditary Hematological Disorders Development Market Report: Overview of all products in therapeutic development for each indication
Nov 6, 2018
. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for thalassemia, hemophilia B and sickle cell anemia, and features dormant and discontinued products.
Pune, India - November 6, 2018 /MarketersMedia/ —
Thalassemia refers to a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms include paleness, frequent infections and jaundice. Predisposing factors include family history. Treatment includes blood transfusions and bone marrow transplant. There are 40 products in development for this indication.
Access Report Details at: https://www.themarketreports.com/report/hereditary-hematological-disorders-drug-development-pipeline-review-2018
Sickle cell anemia is a genetic blood disorder in which red blood cells, which carry oxygen around the body, develop abnormally. Signs and symptoms include anemia, delayed growth, vision problems, pain and frequent infections. Treatment includes antibiotics, pain relievers, blood transfusion and stem cell transplant. There are 68 products in development for this indication.
Molecular targets acted on by products in development for hereditary hematological disorders include coagulation factors, histone deacetylases and protein kinases. Companies operating in this pipeline space include Sangamo Therapeutics, Gamida Cell and Bluebird Bio
Scope
• Which companies are the most active within each pipeline?
• Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
• To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
• What are the most important R&D milestones and data publications to have happened in this disease area?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/1319467
Reasons To Buy
• Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
• Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication and a comprehensive picture of recent updates and milestones for each
• Analyze the companies, institutions and universities currently operating in the pipeline and the products being fielded by each of these
• Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Get this report at: https://www.themarketreports.com/report/buy-now/1319467
Contact Info:
Name: Shirish Gupta
Email: Send Email
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315
For more information, please visit https://www.themarketreports.com/report/hereditary-hematological-disorders-drug-development-pipeline-review-2018
Source: MarketersMedia
Release ID: 439651
More News
OpenAI unveils AI assistant 'dots' while safety worries delay new model
Sam Altman spoke in San Francisco during OpenAI’s annual event for tech developers.
Risks being taken with heating oil orders, firm says
Customers in Berkshire and Hampshire are leaving it late to refill their tanks, an oil firm says.
Facing the future without the 'bank of mum and dad'
Young people struggling to make ends meet respond to the government's Your First Home scheme.
Three takeaways from Trump's 'Super Intelligence' summit
The meeting at the White House came as some tech bosses and experts have called for tighter rules around AI.
China says reported European '301' tool typical act of protectionism
China on Tuesday said a reported tool being pushed by some European Union member states is a typical example of protectionism and unilateralism that would disrupt China-EU trade as well as the stability of global industrial and supply chains.
A.I. Is ‘Better Informed’ Than Doctors, Kennedy Tells Industry-Backed MAHA Summit
The health secretary, Vice President JD Vance and other top officials addressed a conference sponsored by corporations, including A.I. companies and others with business before the government.
Chinese AI tool told researchers how to make bioweapons
Mindgard said it discovered in July that Kimi models K2.6 and K3 Swarm could evade developer's safety limits.
The start-ups hoping to return battery making to the US
Batteries based on sodium-ion technology could be made in the US with locally sourced materials.
Huel ad banned for suggesting its products could replace all meals
The advertising watchdog said that viewers could assume from the ad that replacing all normal food with Huel was "nutritionally appropriate".
X2, the Troubled California Six Flags Roller Coaster, Reaches Its End
The ride at Magic Mountain near Los Angeles has fueled lawsuits claiming that it had caused brain injuries, including two that were fatal.
Paramount’s Streaming Chief Leaves Ahead of Warner Bros. Deal
Cindy Holland’s departure clears the way for Casey Bloys, the HBO chairman, to have a leading role in the combined company’s streaming services.
Mideast Oil Exports Rebound Even as Prices Remain Elevated
More tankers are moving through the Strait of Hormuz as shippers gain confidence, but the global supply of oil is still below demand.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.